FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 ( compounding only, no legal prescribing) into Category 1. This means The FDA's Ban of Therapeutic Peptides: A Threat to Health Freedom Slim 'n Sleek Orthopedic Use of BPC 157 Sports Med Review Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog